Endothelial nitric oxide synthase Glu298Asp (G894T) gene polymorphism in coronary artery disease patients with type 2 diabetes mellitus
Authors:
- Vandana SainiVSVandana Saini
- M.K. BhatnagarMBM.K. Bhatnagar
- Jayashree BhattacharjeeJBJayashree Bhattacharjee
- 1 April 2012
- journal article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 6 (2) , 106-109
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Correlation and Identification of Variable number of Tandem repeats of eNOS Gene in Coronary artery disease (CAD)Saudi Journal of Biological Sciences, 2010
- The Glu298ASP polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican populationClinica Chimica Acta, 2010
- Increased basal levels of plasma nitric oxide in Type 2 diabetic subjectsJournal of Diabetes and its Complications, 2001
- Polymorphisms in endothelial nitric oxide synthase and atherogenesisAtherosclerosis, 2001
- A Common Variant of the Endothelial Nitric Oxide Synthase (Glu298→Asp) Is a Major Risk Factor for Coronary Artery Disease in the UKCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Nitric Oxide Reversibly Inhibits the Migration of Cultured Vascular Smooth Muscle CellsCirculation Research, 1996
- Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.Journal of Clinical Investigation, 1995
- Nitric Oxide Modulates the Expression of Monocyte Chemoattractant Protein 1 in Cultured Human Endothelial CellsCirculation Research, 1995
- Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993